AzTrials
AzTrials

Acute StrokeVIBRASTROKENCT07905625

Effect of Early Tendon Vibrations on Upper Limb Motor Recovery After a Stroke

A study testing TVS rehabilitation sessions in people with Acute Stroke and Upper Limb Motor Deficit, run by Centre Hospitalier Régional d'Orléans at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Strokes often induce a motor deficit. The resulting immobilization is in itself an aggravation factor since it worsens the motor deficit induced by the stroke itself. Amongst the different sensory stimulations, the use of tendon vibratory stimulations (TVS) that activate proprioceptive pathways (muscle spindle fibers)… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Stroke, Upper Limb Motor Deficit
What is being tested?
TVS rehabilitation sessions
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteFrance
Study dates
3 Nov 2026to 3 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Person (or trusted/related person for aphasic patients with understanding impairment) that accepted to participate in the study.
  • Aged ≥ 18-year-old
  • Patient in acute stroke stage (from D1 to D6 post-stroke)
  • Estimated hospitalization stay longer than 8 days.
  • Able to understand and execute simple evaluation instructions (ex: " raise the arm ")
  • SAFE score between 0 and 7 on the affected side.

Who cannot join

  • Other neurological or rheumatological pathology that limit mobility.
  • Somnolence (linked to the stroke or iatrogenic)
  • Bilateral stroke with bilateral motor deficit.
  • Protected person (under tutelage or guardianship)
  • Person under legal protection
  • Person deprived of liberty
  • Person not affiliated to a social security system
  • Pregnant or breastfeeding women.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Centre Hospitalier Universitaire d'Orléans

    Orléans, Loiret, 45067

    Mathilde SARRAZIN, 0238744665 ext. +33, mathilde.sarrazin@chu-orleans.fr

Other trials in France

About this study

Strokes often induce a motor deficit. The resulting immobilization is in itself an aggravation factor since it worsens the motor deficit induced by the stroke itself.

Amongst the different sensory stimulations, the use of tendon vibratory stimulations (TVS) that activate proprioceptive pathways (muscle spindle fibers) is gaining increasing interest in the rehabilitation world.

Read more

Tendon vibratory stimulation (TVS) can be used on patients with little to no voluntary motor functions. Therefore, it seems particularly suited to significant upper limb deficits, and especially as early as possible after a stroke occurs when motor skills are severely affected.

Various studies have shown the interest of using vibratory stimulations in the management of post-stroke motor disorders. The majority were conducted in the chronic stroke stage. Only one small scale study has been conducted on the acute stroke stage.

Read the detailed description

For patients with upper limb function deficit in acute stroke stage, is studied the effect of added tendon vibratory stimulation (TVS) to the usual rehabilitation sessions.

The vibratory stimulation equipment is Vibramoov physio (Techno Concept) 54 patients will be randomized in two groups, stratified on SAFE score and age:

  • Control group: Usual rehabilitation session The usual rehabilitation session implies: passive or active mobilization, stretching, video therapy, robot therapy.
  • Experimental group: Tendon vibratory stimulation (TVS) technique (30min) added before the usual rehabilitation session For the TVS technique: two stimulators will be placed on the distal part of the forearm: the first on the anterior side the second on the posterior side. The patient will receive 3 sets of 10 min stimulation spaced 1min apart. The stimulation frequency is 100 Hz, the amplitude is 2 mm. 10 rehabilitation sessions will occur within a period between 10 and 25 days after inclusion. 3 different time slots are defined for evaluations: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions T3: After 10 rehabilitation session or when the patient leaves (if before 10 sessions with a minimum of 8)

Will be evaluated in the two groups at T1, T2 and T3:

  • Fugl Meyer Assessment (FMA)
  • Shoulder Abduction and Finger Extension score (SAFE)
  • Grip strength (with a Jamar dynamometer)
  • Thumb Localization Test (TLT)
  • Erasmus modified Nottingham Assessment (EmNSA)
  • Modified Ashworth Scale (MAS)
  • Numeric Pain Rating Scale (NPRS)
Being tested
TVS rehabilitation sessions
Keywords
physical therapy, acute stroke, tendon vibratory stimulation, motor skill recovery, upper limb function deficit
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TVS rehabilitation sessionsProcedure or surgery

    Patients randomized in the experimental group will have Tendon vibratory stimulation (TVS) technique (30min) added before their usual rehabilitation session

    Two stimulators will be placed on the distal part of the forearm: the first on the anterior side the second on the posterior side. The patient will receive 3 sets of 10 min stimulation spaced 1min apart. The stimulation frequency is 100 Hz, the amplitude is 2 mm.

Study groups in NCT07905625
Study groupRoleWhat they receive
Tendon vibratory stimulation groupExperimentalPatients randomized in the experimental group will have Tendon vibratory stimulation (TVS) technique (30min) added before their usual rehabilitation session (30min).
Receives: Procedure: TVS rehabilitation sessions
Control groupNo interventionPatients randomized in the control group will have the usual rehabilitation session (30min).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Study whether adding tendon vibratory stimulation (TVS) to the usual rehabilitation sessions on the after upper limb after a stroke improves the recovery of the limb's motor strength.

    Fugl Meyer Assesment (FMA) of the affected limb after 5 rehabilitation session (T2) with or without the TVS. FMA score ranges from 0 to 66, with 0 representing the most severe deficit and 66 representing normal motor function.

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days)

Secondary outcomes (6)
  1. Study the effect of adding TVS rehabilitation on the motor strength of the affected upper limb over time.

    Motor strength of the affected upper limb scored by Shoulder Abduction and Finger Extension (SAFE) Score. The SAFE score is calculated by summing the MRC grades for shoulder abduction and finger extension. The total score ranges from 0 to 10, where 0 represents no voluntary muscle activity in shoulder abduction and finger extension and 10 represents normal strength in both movement.

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

  2. Study the effect of adding TVS rehabilitation on wrist motor strength over time.

    Motor strength of the wrist (on the affected upper limb) is evaluated by subsection n°6 of the Fugl Meyer Assesment (FMA). Score ranges from 0 (severe impairment) to 6 (normal coordination and speed)

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

  3. Study the effect of adding TVS rehabilitation on finger grip strength over time.

    Grip strength evaluated with a Jamar dynamometer (the value retained being the average of 3 tries).

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

  4. Study whether adding TVS rehabilitation improves the conscious deep sensitivity of the affected upper limb over time

    Conscious deep sensitivity of the affected upper limb is evaluated by Thumb Localization Test (TLT). TLT ranges from 0 to 3, where 0 indicates normal thumb localization and 3 indicates severe proprioceptive impairment with inability to accurately locate the thumb.

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

  5. Study whether adding STV therapy reduces spasticity in the affected upper limb over time.

    Spasticity is evaluated by modified Ashworth scale. This scale ranges from 0 (no increase in muscle tone) to 4 (affected part rigid in flexion or extension).

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

  6. Study whether adding STV therapy reduces pain in the affected upper limb over time

    Pain in the affected upper limb is evaluated by Visual Analogue Scale (VAS). The VAS ranges from 0 to 10. 0 represents the worst pain and 10 represents no pain.

    Measured: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days) T3: After 10 rehabilitation session (up to 25 days) or when the patient leaves (if before 10 sessions with a minimum of 8)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study start3 Nov 2026 (estimated)
  3. Primary completion3 Dec 2028 (estimated)
  4. Study completion3 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective, controlled, randomized, single-blind study
Masking
Single blind
Who is masked
Investigator
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07905625
Sponsor's protocol ID
CHUO-2026-05
Acronym
VIBRASTROKE
Status last verified
Oct 2026
First submitted
15 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing TVS rehabilitation sessions in people with Acute Stroke and Upper Limb Motor Deficit, run by Centre Hospitalier Régional d'Orléans at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mathilde Sarrazin (0238744665 ext. +33, mathilde.sarrazin@chu-orleans.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Study whether adding tendon vibratory stimulation (TVS) to the usual rehabilitation sessions on the after upper limb after a stroke improves the recovery of the limb's motor strength. (time frame: T1: Right before the first rehabilitation session T2: After 5 rehabilitation sessions (up to 7 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in